A. Karin Navarro-Mtz

Prof. A. Karin Navarro-Mtz

Universidad del Papaloapan
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Food Research International
Verified
Journal Article
Closed access
Erick Adrian Juarez-ArellanoErick Adrian Juarez-Arellano
Erick Adrian Juarez-Arellano
MUM. Urzua-Valenzuela
M. Urzua-Valenzuela
MPM.A. Peña-Rico
M.A. Peña-Rico
AAA. Aparicio-Saguilan
A. Aparicio-Saguilan
MVM. Valera-Zaragoza
M. Valera-Zaragoza
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz

1 June 2014 in Bioresource Technology
Verified
Journal Article
Closed access
Luis Guerrero-CabreraLuis Guerrero-Cabrera
Luis Guerrero-Cabrera
JRJosé A. Rueda
José A. Rueda
HGHiram García-Lozano
Hiram García-Lozano
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz

1 February 2021 in Advanced Powder Technology
Verified
Journal Article
Closed access
MVMario Valera-Zaragoza
Mario Valera-Zaragoza
DADiana Agüero-Valdez
Diana Agüero-Valdez
MLMargarita Lopez-Medina
Margarita Lopez-Medina
SDShunashi Dehesa-Blas
Shunashi Dehesa-Blas
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz
Erick Adrian Juarez-ArellanoErick Adrian Juarez-Arellano
Erick Adrian Juarez-Arellano

1 November 2019 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
AMA. Martinez-Garcia
A. Martinez-Garcia
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz
CNC. Neun
C. Neun
LBL. Bayarjargal
L. Bayarjargal
WMW. Morgenroth
W. Morgenroth
Erick Adrian Juarez-ArellanoErick Adrian Juarez-Arellano
Erick Adrian Juarez-Arellano

1 May 2006 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz
RFReynold R. Farrera
Reynold R. Farrera
RLRuth López
Ruth López
FPFermín Pérez-Guevara
Fermín Pérez-Guevara

9 July 2021 in Toxins
Verified
Journal Article
Open access
PDF file
DBDiego Becker Borin
Diego Becker Borin
KCKaren Castrejón-Arroyo
Karen Castrejón-Arroyo
ACAlain Cruz-Nolasco
Alain Cruz-Nolasco
MRMiguel Angel Peña Rico
Miguel Angel Peña Rico
MSMichele Sagrillo
Michele Sagrillo
A. Karin Navarro-MtzA. Karin Navarro-Mtz
A. Karin Navarro-Mtz
The protein A13-2 was obtained from Bacillus thuringiensis strains isolated from the Papaloapan watershed region (Oaxaca, Mexico). The cytotoxic activity of parasporal inclusions was studied against breast cancer cell line (MCF-7) and normal cell (human peripheral blood mononuclear cells). The MTT, the formation of reactive species, nitric oxide, free cell DNA, and the type of death cellular were assessed. The protein A13-2 shows the highest cytotoxic activity against MCF-7 (13% cell viability at 6 µg/mL), the extracellular DNA increases, and it shows no stress for reactive species or nitric oxide. Besides, the A13-2 parasporin shows no toxicity to peripheral blood mononuclear cells, and it does not generate changes in nitric oxide levels or free cell DNA. Due to that, the cytotoxic effect of A13-2 was specific for MCF-7, and it does not affect normal cells. According to microscopy and flow cytometry, A13-2 parasporin leads to the death of MCF-7 cells by late apoptosis together with necrosis and without allowing the triggering of the survival mechanisms. When analyzed together, our results show for the first time that the A13-2 protein isolated from Mexican strains of B. thuringiensis preferentially kills MCF- 7 (cancer cells) over HEK 293 and PBMC cell lines (normal cells), thus representing a promising alternative for the treatment of cancer breast.